Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Carlsmed (CARL) Equity Average (2024 - 2025)

Carlsmed (CARL) has disclosed Equity Average for 2 consecutive years, with $102.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Equity Average rose 250.4% year-over-year to $102.8 million, compared with a TTM value of $102.8 million through Dec 2025, up 250.4%, and an annual FY2025 reading of $14.1 million, changed N/A over the prior year.
  • Equity Average was $102.8 million for Q4 2025 at Carlsmed, up from $11.8 million in the prior quarter.
  • Across five years, Equity Average topped out at $102.8 million in Q4 2025 and bottomed at -$76.9 million in Q2 2025.